TGI Solar Power Group Inc. (TSPG)
| Previous Close | 0.0019 |
| Open | 0.0015 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0014 - 0.0015 |
| 52 Week Range | 0.0003 - 0.0043 |
| Volume | |
| Avg. Volume | 811,944 |
| Market Cap | 2.387M |
| Beta (5Y Monthly) | 2.25 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0000 |
| Earnings Date | Jun 14, 2024 - Jun 18, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ACCESSWIRETGI/BIOVET CGT and Ela Pharma Announce Joint Development and Commercialization Agreement
MIAMI, FL / ACCESSWIRE / January 5, 2024 / TGI Solar Power Group, Inc. (OTC Markets:TSPG), through its subsidiary BIOVET CGT, a veterinarian biotechnology company, has entered into a research and development agreement with ELA Pharma (ELA) https://www.elapharma.com/. ...
ACCESSWIRETGI Solar Power Group, Inc. has Formed a Joint Venture with BIOVET Technologies, Inc. to bring Novel Therapies and Technologies to the Veterinary Field
MIAMI, FL / ACCESSWIRE / December 20, 2023 / BioVet CGT, Inc. a joint venture of TGI Solar Power Group, Inc., (OTC PINK:TSPG) ("TGI") and BioVet Technologies, Inc. ("BioVet"), announced today it has been formed to commercialize cell and gene therapies ...
- ACCESSWIRE
TGI Enters into Definitive Agreement to Acquire New Class of Assets Focused on Cell and Gene Therapies to be Operated as BIOVET CGT INC.
MIAMI, FL / ACCESSWIRE / October 5, 2023 / TGI Solar Power Group, Inc., (OTC Pink:TSPG) ("TGI"), today announced the acquisition of new class of assets, a veterinarian biotechnology company focused on: discovery and development of novel cell and gene ...
